AWKN — Awakn Life Sciences Balance Sheet
0.000.00%
Last trade - 00:00
- CA$6.56m
- CA$6.01m
- CA$1.50m
2021 January 31st | 2022 January 31st | 2023 January 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash | |||
Cash and Short Term Investments | 0.366 | 1.62 | 0.551 |
Net Total Accounts Receivable | |||
Net Total Receivables | 0.018 | 0.13 | 0.143 |
Prepaid Expenses | |||
Total Current Assets | 0.477 | 2.11 | 0.975 |
Net Property, Plant And Equipment | 0.349 | 3.61 | 2.95 |
Net Goodwill | |||
Net Intangible Assets | |||
Other Long Term Assets | |||
Total Assets | 0.825 | 6.88 | 4.39 |
Payable / Accrued | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 0.242 | 1.86 | 2.46 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Minority Interest | |||
Total Other Liabilities | |||
Total Liabilities | 0.498 | 3.46 | 3.55 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | 0.328 | 3.41 | 0.848 |
Total Liabilities & Shareholders' Equity | 0.825 | 6.88 | 4.39 |
Total Common Shares Outstanding |